About
Elizabeth Parrish is the founder and CEO of BioViva, a Seattle-area gene-therapy company focused on aging-related diseases and longevity. She became widely known after publicly undergoing experimental gene therapies promoted by BioViva and has since operated as a high-visibility advocate for regenerative medicine and longevity. Public sources connect her to longevity community organizations and conference/advisory roles, but not to documented personal investing activity.
Areas of interest
longevitygene therapybiotechregenerative medicineaging biologyAlzheimer's diseasepublic education